FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

1050951000168102: Australian Schedule 8 controlled medications reference set (foundation metadata concept)


Status: current, Primitive. Date: 30-Apr 2018. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
2162761000168119 Australian Schedule 8 controlled medications reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
2162771000168113 Australian Schedule 8 controlled medications reference set en Synonym Active Case sensitive Australian Medicines Terminology module
2162781000168111 Schedule 8 medications reference set en Synonym Active Case insensitive Australian Medicines Terminology module
2162791000168114 Schedule 8 controlled drug reference set en Synonym Active Case insensitive Australian Medicines Terminology module
4351601000168114 <p>Supports the identification of AMT MPUU, MPP, TPUU and CTPP concepts that are listed as Schedule 8 Controlled Drugs (S8) under the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP).</p><p>This reference set can be used by dispensing systems to identify controlled medications for Electronic Recording and Reporting of Controlled Drugs (ERRCD) requirements.</p><p><b>Target client: </b>This reference set can be used by developers to assist with the requirements of ERRCD reporting.</p> en Definition Active Case sensitive Australian Medicines Terminology module


3976 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Schedule 8 medications reference set Is a Reference sets for Medications true Inferred relationship Some
Schedule 8 medications reference set Is a Simple type reference set true Inferred relationship Some
Schedule 8 medications reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 630031775
Schedule 8 medications reference set Developed by Australian Digital Health Agency true Inferred relationship Some 1378992300

Members
Palexia SR 200 mg modified release tablet
Palexia SR 200 mg modified release tablet, 10, blister pack
Palexia SR 200 mg modified release tablet, 100, blister pack
Palexia SR 200 mg modified release tablet, 14, blister pack
Palexia SR 200 mg modified release tablet, 20, blister pack
Palexia SR 200 mg modified release tablet, 28, blister pack
Palexia SR 200 mg modified release tablet, 30, blister pack
Palexia SR 200 mg modified release tablet, 40, blister pack
Palexia SR 200 mg modified release tablet, 50, blister pack
Palexia SR 200 mg modified release tablet, 56, blister pack
Palexia SR 200 mg modified release tablet, 60, blister pack
Palexia SR 200 mg modified release tablet, 7, blister pack
Palexia SR 200 mg modified release tablet, 90, blister pack
Palexia SR 25 mg modified release tablet
Palexia SR 25 mg modified release tablet, 10, blister pack
Palexia SR 25 mg modified release tablet, 100, blister pack
Palexia SR 25 mg modified release tablet, 14, blister pack
Palexia SR 25 mg modified release tablet, 20, blister pack
Palexia SR 25 mg modified release tablet, 28, blister pack
Palexia SR 25 mg modified release tablet, 30, blister pack
Palexia SR 25 mg modified release tablet, 40, blister pack
Palexia SR 25 mg modified release tablet, 50, blister pack
Palexia SR 25 mg modified release tablet, 56, blister pack
Palexia SR 25 mg modified release tablet, 60, blister pack
Palexia SR 25 mg modified release tablet, 7, blister pack
Palexia SR 25 mg modified release tablet, 90, blister pack
Palexia SR 250 mg modified release tablet
Palexia SR 250 mg modified release tablet, 10, blister pack
Palexia SR 250 mg modified release tablet, 100, blister pack
Palexia SR 250 mg modified release tablet, 14, blister pack
Palexia SR (tapentadol 250 mg) modified release tablet, 20 tablets, blister pack (containered trade product pack)
Palexia SR 250 mg modified release tablet, 28, blister pack
Palexia SR 250 mg modified release tablet, 30, blister pack
Palexia SR 250 mg modified release tablet, 40, blister pack
Palexia SR 250 mg modified release tablet, 50, blister pack
Palexia SR (tapentadol 250 mg) modified release tablet, 56 tablets, blister pack (containered trade product pack)
Palexia SR 250 mg modified release tablet, 60, blister pack
Palexia SR 250 mg modified release tablet, 7, blister pack
Palexia SR 250 mg modified release tablet, 90, blister pack
Palexia SR 50 mg modified release tablet
Palexia SR 50 mg modified release tablet, 10, blister pack
Palexia SR 50 mg modified release tablet, 100, blister pack
Palexia SR 50 mg modified release tablet, 14, blister pack
Palexia SR 50 mg modified release tablet, 20, blister pack
Palexia SR 50 mg modified release tablet, 28, blister pack
Palexia SR 50 mg modified release tablet, 30, blister pack
Palexia SR 50 mg modified release tablet, 40, blister pack
Palexia SR 50 mg modified release tablet, 50, blister pack
Palexia SR (tapentadol 50 mg) modified release tablet, 56 tablets, blister pack (containered trade product pack)
Palexia SR 50 mg modified release tablet, 60, blister pack
Palexia SR 50 mg modified release tablet, 7, blister pack
Palexia SR 50 mg modified release tablet, 90, blister pack
Palladone XL 12 mg modified release capsule
Palladone XL 12 mg modified release capsule, 10, bottle
Palladone XL 12 mg modified release capsule, 30, bottle
Palladone XL 16 mg modified release capsule
Palladone XL 16 mg modified release capsule, 10, bottle
Palladone XL 16 mg modified release capsule, 30, bottle
Palladone XL 24 mg modified release capsule
Palladone XL 24 mg modified release capsule, 10, bottle
Palladone XL 24 mg modified release capsule, 30, bottle
Palladone XL 32 mg modified release capsule
Palladone XL 32 mg modified release capsule, 10, bottle
Palladone XL 32 mg modified release capsule, 30, bottle
Pecfent 100 microgram/actuation nasal spray, 4 x 8 actuations, pump packs
Pecfent 100 microgram/actuation nasal spray, 8 actuations, pump pack
Pecfent 100 microgram/actuation nasal spray, actuation
Pecfent (fentanyl 400 microgram / 1 actuation) nasal spray, 4 x 8 actuations, pump packs (containered trade product pack)
Pecfent 400 microgram/actuation nasal spray, 8 actuations, pump pack
Pecfent 400 microgram/actuation nasal spray, actuation
Pethidine (AstraZeneca) 100 mg/2 mL injection, 10 x 2 mL ampoules
Pethidine (AstraZeneca) 100 mg/2 mL injection, 2 mL ampoule
Pethidine (AstraZeneca) 100 mg/2 mL injection, 5 x 2 mL ampoules
Pethidine (AstraZeneca) 100 mg/2 mL injection, 50 x 2 mL ampoules
Pethidine (Juno) 100 mg/2 mL injection, 10 x 2 mL ampoules
Pethidine (Juno) 100 mg/2 mL injection, 2 mL ampoule
Pethidine (Juno) 100 mg/2 mL injection, 5 x 2 mL ampoules
Pethidine (Juno) 100 mg/2 mL injection, 50 x 2 mL ampoules
Pethidine Hydrochloride (DBL) 100 mg/2 mL injection, 2 mL ampoule
Pethidine Hydrochloride (DBL) 100 mg/2 mL injection, 5 x 2 mL ampoules
Pethidine Hydrochloride (DBL) 100 mg/2 mL injection, 50 x 2 mL ampoules
Pethidine Hydrochloride (DBL) 25 mg/mL injection, ampoule
Pethidine Hydrochloride (DBL) 25 mg/mL injection, 5 x 1 mL ampoules
Pethidine Hydrochloride (DBL) 50 mg/mL injection, ampoule
Pethidine Hydrochloride (DBL) 50 mg/mL injection, 5 x 1 mL ampoules
Pethidine Hydrochloride (DBL) 50 mg/mL injection, 50 x 1 mL ampoules
Pethidine Hydrochloride (DBL) (pethidine hydrochloride 500 mg / 10 mL) injection, 10 mL vial (trade product unit of use)
Pethidine Hydrochloride (DBL) 500 mg/10 mL injection, 10 x 10 mL vials
Pethidine Hydrochloride (DBL) 75 mg/1.5 mL injection, 1.5 mL ampoule
Pethidine Hydrochloride (DBL) 75 mg/1.5 mL injection, 5 x 1.5 mL ampoules
Pethidine Hydrochloride (DBL) 75 mg/1.5 mL injection, 50 x 1.5 mL ampoules
Physeptone 10 mg/mL injection, ampoule
Physeptone 10 mg/mL injection, vial
Physeptone 10 mg/mL injection, 5 x 1 mL ampoules
Physeptone 10 mg/mL injection, 5 x 1 mL vials
Physeptone 10 mg tablet
Physeptone 10 mg tablet, 20, blister pack
Physeptone 10 mg tablet, 20, bottle
Physeptone 5 mg tablet
Physeptone 5 mg tablet, 20, bottle
Physeptone Liquid 5 mg/mL oral liquid

Start Previous Page 24 of 40 Next End


Reference Sets

Reference set descriptor

Back to Start